Enhanced and resumed GB virus C replication in HIV-1-infected individuals receiving HAART
- 31 July 2007
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 21 (12) , 1641-1643
- https://doi.org/10.1097/qad.0b013e32823bc9b7
Abstract
In patients co-infected with HIV-1 and GB virus C (GBV-C), the disappearance of GBV-C RNA has been associated with accelerated disease progression. We studied longitudinal GBV-C viral titres in 28 HIV-1/GVB-C co-infected individuals receiving HAART. During HAART, median GBV-C RNA titres increased from 95 to 6000 copies/ml (P < 0.001). In patients interrupting HAART, GBV-C-RNA titres decreased as HIV replication resumed. These findings further support the theory that GBV-C replication could depend on the dynamics of HIV progression.Keywords
This publication has 12 references indexed in Scilit:
- GB Virus C Coinfection and HIV‐1 Disease Progression: The Amsterdam Cohort StudyThe Journal of Infectious Diseases, 2005
- GB virus C during the natural course of HIV-1 infectionAIDS, 2004
- Persistent GB Virus C Infection and Survival in HIV-Infected MenNew England Journal of Medicine, 2004
- No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patientsAIDS, 2002
- Infection with GB Virus C and Reduced Mortality among HIV-Infected PatientsNew England Journal of Medicine, 2001
- Effect of Coinfection with GB Virus C on Survival among Patients with HIV InfectionNew England Journal of Medicine, 2001
- Effect of Hepatitis G Virus Infection on Progression of HIV Infection in Patients with HemophiliaAnnals of Internal Medicine, 2000
- Influence of RNA titre and amino acid changes in the NS5A region of GB virus C/hepatitis G virus on the effectiveness of interferon therapyJournal of Gastroenterology and Hepatology, 2000
- Carriage of GB Virus C/Hepatitis G Virus RNA Is Associated with a Slower Immunologic, Virologic, and Clinical Progression of Human Immunodeficiency Virus Disease in Coinfected PersonsThe Journal of Infectious Diseases, 1999
- Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infectionHepatology, 1998